You're been inactive for a while. For security reason, we'll automatically sign you out from our website. Please Click "Login" to extend your session
Access your patient history, lab results, future appointments and more.
Login via mobile number is currently unavailable. Our apologies for the inconvenience.
New to Bumrungrad? Create Account
Explore the latest news and easily book appointments with our world-class doctors.
Already have an account? Log In
Selected Filter (s): All
Type : All
Clear All
Constipation is a common problem in children. The symptoms may be mild, and parents may not recognize it as a problem until it becomes chronic, affecting health, growth, learning, and daily activities.
A transformative study has shown that combining Endoscopic Sleeve Gastroplasty (ESG) with GLP-1 receptor agonist drugs, such semaglutide, delivers superior weight loss results compared to ESG alone. It is changing the landscape of obesity treatment.
Looking for safe, effective, and minimally invasive weight loss options? Bumrungrad International Hospital offers the latest Endoscopic Sleeve Gastroplasty (ESG) techniques to help you achieve sustainable weight loss.
Obesity is a significant health concern, affecting millions and placing a heavy burden on healthcare systems. If you’re exploring weight-loss options, two effective approaches are Endoscopic Sleeve Gastroplasty (ESG) and GLP-1 drugs like semaglutide.
Obesity is a growing global challenge. By 2030, more than 1 billion people are expected to struggle with it. Endoscopic Sleeve Gastroplasty (ESG) offers a middle ground—a safe, effective, and less invasive way to lose weight and improve your health.